Skip Navigation

A Phase II Open-Label Study of Enfortumab Vedotin in Patients with Previously Treated Locally Advanced, Recurrent, or Metastatic Pancreatic Adenocarcinoma EPIC

Brief Summary

Type:
Pancreatic

Study Type:
Treatment

Phase:
II

ClinicalTrials.gov Identifier:
NCT05915351

Study #:
STUDY00150104

Start Date:
May 22, 2023

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT05915351

View Complete Trial Details & Eligibility at ClinicalTrials.gov